Prilosec and Nexium heart risk reviewed by FDA

Prilosec and Nexium, two popular heartburn drugs, are being reviewed by the FDA due to concerns that they may increase the risk of heart problems.  Although data submitted to federal regulators from two long-term studies indicate users suffered more heart related injuries, a preliminary analysis by… Read More

Austin Kirk

By
August 10, 2007 | No Comments

FDA Video: MRI contrast dye warnings due to risk of NSF

The latest edition of the FDA Patient Safety News webcast features a segment about the dangers of MRI contrast agents containing gadolinium.  For individuals with kidney failure, the MRI contrast dyes could lead to a serious condition called nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing demopathy… Read More

Austin Kirk

By
August 6, 2007 | 1 Comment